Epidarex Capital Invests in Cancer Drug Developer Confluence Life Sciences Inc
February 18, 2014
Bethesda, MD, February 18, 2014 – Epidarex Capital, a leading international early-stage life science venture capital fund, has invested in Confluence Life Sciences Inc., a